Publications by authors named "Pascal Schnalke"

Claim this Profile
A
Antiangiogenic Properties of Axitinib versus Sorafenib Following Sunitinib Resistance in Human Endothelial Cells-A View towards Second Line Renal Cell Carcinoma Treatment.
Eva Juengel, Pascal Schnalke, Jochen Rutz, Sebastian Maxeiner, Felix K-H Chun

Biomedicinesยท November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis